A carregar...
Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors
PURPOSE: Paclitaxel, ifosfamide, and cisplatin (TIP) achieved complete responses (CRs) in two thirds of patients with advanced germ cell tumors (GCTs) who relapsed after first-line chemotherapy with cisplatin and etoposide with or without bleomycin. We tested the efficacy of first-line TIP in patien...
Na minha lista:
Publicado no: | J Clin Oncol |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
American Society of Clinical Oncology
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5320896/ https://ncbi.nlm.nih.gov/pubmed/27185842 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.66.7899 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|